Velocity Clinical Research

Overview

Velocity Clinical Research is a U.S.-based company specializing in clinical trial management and patient enrollment services within the research and development sector of the business services industry. Founded in 2017, the company has established a network of clinical trial sites across the United States, Germany, and the United Kingdom, facilitating participation in a variety of vaccine and treatment trials. Its documented expertise includes managing large-scale Phase 3 and Phase 4 clinical trials, such as a multinational vaccine trial targeting adults aged 50 and older, where it successfully enrolled over 5,700 participants. Additionally, Velocity was involved in a Phase 4 vaccine trial for adolescents and young adults, achieving full enrollment of 1,000 participants. The company also supports decentralized trials, as evidenced by its role in the BATURA trial for asthma treatment, where it exceeded enrollment targets. Velocity emphasizes operational excellence and aims to reflect U.S. demographics in its participant populations, contributing to the diversity of clinical research.

Industry